Identification of RORg(+)T Cells as Key Players in Thyroid Autoimmunity From Checkpoint Immunotherapy

Purpose: Immune checkpoint inhibitors (ICI) are powerful new cancer therapies that leverage the body’s own immune system to attack cancer cells. Unfortunately, their use may be limited by the development of immune-related adverse events (IrAE) in up to 60% of patients. Thyroiditis is a common IrAE,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lechner, Melissa G, Yakobian, Natalie, Patel, Anushi, Rodriguez, Eduardo, Angell, Trevor E, Drakaki, Alexandra, Famini, Pouyan, Praw, Stephanie Smooke, Ribas, Antoni, Su, Maureen A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090248/
http://dx.doi.org/10.1210/jendso/bvab048.1714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090248/
http://dx.doi.org/10.1210/jendso/bvab048.1714

Ejemplares similares